{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:44:00Z","timestamp":1786718640156,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/njcp.njcp_221_17","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T01:18:08Z","timestamp":1525396688000},"page":"658","source":"Crossref","is-referenced-by-count":12,"title":["Effects of a cyclic NSAID regimen on levels of gingival crevicular fluid prostaglandin E\n                    <sub>2<\/sub>\n                    and Interleukin-1\u03b2: A 6-month randomized controlled clinical trial"],"prefix":"10.4103","volume":"21","author":[{"given":"BF","family":"Oduncuoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"Kayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Haliloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Serpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ataoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NO","family":"Alptekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.231889-1","first-page":"114","volume-title":"Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)","author":"Caton","year":"2011","journal-title":"Pharmacol Res"},{"key":"key-10.4103\/1119-3077.231889-2","first-page":"1592","volume-title":"Host-response therapeutics for periodontal diseases","author":"Giannobile","year":"2008","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-3","first-page":"12","volume-title":"Periodontal host modulation with anti-proteinase, anti-inflammatory, and bone-sparing agents: A systemic review","author":"Reddy","year":"2003","journal-title":"Ann Periodontol"},{"key":"key-10.4103\/1119-3077.231889-4","first-page":"85","volume-title":"The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease","author":"Noguchi","year":"2000","journal-title":"Periodontol"},{"key":"key-10.4103\/1119-3077.231889-5","first-page":"432","volume-title":"Modulation of host PGE2 secretion as a determinant of periodontal disease expression","author":"Offenbacher","year":"1993","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-6","first-page":"498","volume-title":"Inhibition of alveolar bone loss in beagles with the NSAID naproxen","author":"Howell","year":"1991","journal-title":"J Periodontal Res"},{"key":"key-10.4103\/1119-3077.231889-7","first-page":"485","volume-title":"Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen","author":"Williams","year":"1989","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-8","first-page":"828","volume-title":"Blocking periodontal disease progression with anti-inflammatory agents","author":"Howell","year":"1993","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-9","first-page":"1676","volume-title":"Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation","author":"B\u00e5ge","year":"2011","journal-title":"Am J Pathol"},{"key":"key-10.4103\/1119-3077.231889-10","first-page":"253","volume-title":"Synergistic interactions of bradykinin, thrombin, interleukin 1 and tumor necrosis factor on prostanoid biosynthesis in human periodontal-ligament cells","author":"Ransj\u00f6","year":"1998","journal-title":"Arch Oral Biol"},{"key":"key-10.4103\/1119-3077.231889-11","first-page":"3473","volume-title":"Regulation of tumor necrosis factor\/cachectin and IL-1 secretion in human mononuclear phagocytes","author":"Burchett","year":"1988","journal-title":"J Immunol"},{"key":"key-10.4103\/1119-3077.231889-12","first-page":"1464","volume-title":"Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption","author":"Stashenko","year":"1987","journal-title":"J Immunol"},{"key":"key-10.4103\/1119-3077.231889-13","first-page":"358","volume-title":"Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: Synergy with parathyroid hormone","author":"Tatakis","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"key-10.4103\/1119-3077.231889-14","first-page":"2474","volume-title":"Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1)","author":"Mizel","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/1119-3077.231889-15","first-page":"548","volume-title":"Levels of interleukin 1 beta in tissue from sites of active periodontal disease","author":"Stashenko","year":"1991","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-16","first-page":"468","volume-title":"Three-year clinical trial of flurbiprofen treatment in humans: Post-treatment period","author":"Williams","year":"1991","journal-title":"J Dent Res"},{"key":"key-10.4103\/1119-3077.231889-17","first-page":"215","volume-title":"The use of topical subgingival gels of non-steroidal anti-inflammatory drugs (NSAIDs) as an adjunct to non-surgical management of chronic periodontitis","author":"Funosas","year":"2009","journal-title":"Acta Odontol Latinoam"},{"key":"key-10.4103\/1119-3077.231889-18","first-page":"329","volume-title":"A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis","author":"Jeffcoat","year":"1995","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-19","first-page":"207","volume-title":"Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss","author":"Offenbacher","year":"1992","journal-title":"J Periodontal Res"},{"key":"key-10.4103\/1119-3077.231889-20","first-page":"2191","volume-title":"Dual COX inhibition and upper gastrointestinal damage","author":"Skelly","year":"2003","journal-title":"Curr Pharm Des"},{"key":"key-10.4103\/1119-3077.231889-21","first-page":"1092","volume-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1119-3077.231889-22","first-page":"590","volume-title":"Nonsteroidal anti-inflammatory drug use in dentistry: Gastrointestinal implications","author":"Nguyen","year":"1999","journal-title":"Gen Dent"},{"key":"key-10.4103\/1119-3077.231889-23","first-page":"7563","volume-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/1119-3077.231889-24","first-page":"5","volume-title":"Pharmacological properties of diclofenac sodium and its metabolites","author":"Menass\u00e9","year":"1978","journal-title":"Scand J Rheumatol Suppl"},{"key":"key-10.4103\/1119-3077.231889-25","first-page":"9","volume-title":"Periodontal diagnoses and classification of periodontal diseases","author":"Armitage","year":"2000","journal-title":"Periodontol"},{"key":"key-10.4103\/1119-3077.231889-26","unstructured":"L\u00f6e H, Sillnes J. Periodontal disease in pregnancy. I. Prevelance and severity. Acta Odontol Scand 1965;21:535-51."},{"key":"key-10.4103\/1119-3077.231889-27","first-page":"129","volume-title":"Influence of periodontal health on probing depth and bleeding tendency","author":"van","year":"1980","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-28","first-page":"327","volume-title":"Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: Their relations to periodontal status","author":"Nakashima","year":"1994","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-29","first-page":"15","volume-title":"Prostaglandin E2 concentrations in gingival crevicular fluid: Observations in untreated chronic periodontitis","author":"Preshaw","year":"2002","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-30","first-page":"1757","volume-title":"The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases","author":"Salvi","year":"2005","journal-title":"Curr Pharm Des"},{"key":"key-10.4103\/1119-3077.231889-31","first-page":"57","volume-title":"Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis","author":"Vardar","year":"2003","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-32","first-page":"868","volume-title":"Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid","author":"Aras","year":"2007","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-33","first-page":"104","volume-title":"The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis","author":"Yen","year":"2008","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-34","first-page":"261","volume-title":"The efficacy of host response modulation therapy (omega-3 plus low- dose aspirin) as an adjunctive treatment of chronic periodontitis (Clinical and bio-chemical study): A randomized, double-blind, placebo-controlled study","author":"Elkhouli","year":"2011","journal-title":"J Periodontol Res"},{"key":"key-10.4103\/1119-3077.231889-35","first-page":"1535","volume-title":"Levels of interleukin-1\u03b2, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment","author":"Gamonal","year":"2000","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-36","first-page":"89","volume-title":"Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota","author":"Teles","year":"2010","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-37","first-page":"1082","volume-title":"Evidence for the early onset of gingival inflammation following short-term plaque accumulation","author":"Zhang","year":"2002","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-38","first-page":"1457","volume-title":"Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis","author":"Figueredo","year":"1999","journal-title":"J Periodontol"},{"key":"key-10.4103\/1119-3077.231889-39","first-page":"48","volume-title":"GCF IL-1beta profiles in periodontal disease","author":"Engebretson","year":"2002","journal-title":"J Clin Periodontol"},{"key":"key-10.4103\/1119-3077.231889-40","first-page":"729","volume-title":"Amount of interleukin-1\u03b2 and interleukin-1 receptor antagonist in periodontitis and healthy patients","author":"Gilowski","year":"2014","journal-title":"Arch Oral Biol"},{"key":"key-10.4103\/1119-3077.231889-41","first-page":"2131","volume-title":"Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts","author":"Yucel-Lindberg","year":"2006","journal-title":"Cell Signal"},{"key":"key-10.4103\/1119-3077.231889-42","first-page":"259","volume-title":"The effect of age on prostaglandin-synthesizing enzymes in the development of gingivitis","author":"Siegel","year":"2007","journal-title":"J Periodontal Res"},{"key":"key-10.4103\/1119-3077.231889-43","first-page":"3942","volume-title":"Lymphocytes produce IL-1beta in response to fcgamma receptor cross-linking: Effects on parenchymal cell IL-8 release","author":"Marsh","year":"1998","journal-title":"J Immunol"},{"key":"key-10.4103\/1119-3077.231889-44","first-page":"731462","volume-title":"Possible potentiation by certain antioxidants of the anti-inflammatory effects of diclofenac in rats","author":"Abbas","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"key-10.4103\/1119-3077.231889-45","first-page":"120","volume-title":"Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation","author":"Cruz","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/1119-3077.231889-46","first-page":"15","volume-title":"A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis","author":"Dugina","year":"2005","journal-title":"Int J Tissue React"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:49Z","timestamp":1786714669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_221_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["231889"],"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_221_17","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}